Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Hyperparathyroidism (SHPT)”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Not applicableStudy completedNCT01149291
What this trial is testing

Follow-up Patients With End Stage Renal Disease Undergoing Hemodialysis, Receiving Selective Vitamin D Receptor Activator's for Prevention and Treatment of Secondary Hyperparathyroidism

Who this might be right for
Secondary HyperparathyroidismEnd Stage Renal Disease
AbbVie (prior sponsor, Abbott) 511
Large-scale testing (Phase 3)Study completedNCT01219855
What this trial is testing

Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismVitamin D Insufficiency
OPKO Health, Inc. 78
Early research (Phase 1)Study completedNCT02833857
What this trial is testing

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

Who this might be right for
Chronic Kidney Disease, Secondary Hyperparathyroidism
Amgen 11
Post-approval studies (Phase 4)Study completedNCT00418600
What this trial is testing

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 36
Large-scale testing (Phase 3)Study completedNCT03299244
What this trial is testing

Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 637
Not applicableStudy completedNCT01224782
What this trial is testing

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 994
Post-approval studies (Phase 4)Study completedNCT03123406
What this trial is testing

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

Who this might be right for
Hyperparathyroidism; Secondary, Renal
Kyowa Kirin China Pharmaceutical Co., Ltd. 750
Large-scale testing (Phase 3)Study completedNCT02102204
What this trial is testing

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 902
Post-approval studies (Phase 4)Study completedNCT00110890
What this trial is testing

A Research Study for Patients With End-Stage Renal Disease (ESRD)

Who this might be right for
End Stage Renal Disease
Amgen 552
Testing effectiveness (Phase 2)Study completedNCT06690242
What this trial is testing

MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 115
Post-approval studies (Phase 4)Study completedNCT01181531
What this trial is testing

Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 312
Testing effectiveness (Phase 2)Study completedNCT02133404
What this trial is testing

Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Astellas Pharma Inc 62
Large-scale testing (Phase 3)Study completedNCT01896232
What this trial is testing

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 683
Testing effectiveness (Phase 2)Ended earlyNCT03602261
What this trial is testing

Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI

Who this might be right for
Secondary Hyperparathyroidism Due to Renal CausesChronic Kidney DiseasesVitamin D Deficiency+1 more
OPKO Health, Inc. 44
Large-scale testing (Phase 3)Ended earlyNCT04064827
What this trial is testing

Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)
AbbVie 2
Early research (Phase 1)Study completedNCT00792857
What this trial is testing

Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)

Who this might be right for
Chronic Kidney DiseaseSecondary HyperparathyroidismChronic Renal Insufficiency+1 more
OPKO IP Holdings II, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00113958
What this trial is testing

Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels

Who this might be right for
End Stage Renal Disease
Amgen
Large-scale testing (Phase 3)Looking for participantsNCT03969329
What this trial is testing

Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Amgen 24
Testing effectiveness (Phase 2)Looking for participantsNCT06976177
What this trial is testing

Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance Dialysis

Who this might be right for
Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 310
Not applicableStudy completedNCT01083849
What this trial is testing

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

Who this might be right for
Kidney InsufficiencySecondary Hyperparathyroidism
AbbVie (prior sponsor, Abbott) 761
Load More Results